Scholarlink

<p>High spatiotemporal precision in targeted drug delivery and controlled activation remains a significant challenge in cancer theranostics due to the complex tumor microenvironment (TME). Here, we introduce a sequential near-infrared (NIR) light-assisted, TME-responsive nanoplatform (GA/cypate@MP-Pap) that employs a two-step NIR light activation strategy for <i>in situ</i> self-assembly of a metal-phenolic network, enabling deep-tissue photoacoustic (PA) imaging and enhanced photothermal therapy (PTT). Upon initial NIR light exposure, the nanoplatform activates thermophilic enzymes, triggering selective degradation of the tumor stroma, which significantly enhances its penetration into deeper tumor regions. Within the TME, the nanoplatform disassembles, releasing Mn<sup>2+</sup> and GA that chelate to form photothermally potent metal-phenolic networks. A subsequent NIR light exposure then amplifies PA signals and PTT efficacy, precisely targeting tumor cells with minimized effects on normal tissues. This dual NIR light-triggered, enzyme-activated strategy provides a novel approach for imaging-guided cancer therapy with high precision both spatially and temporally.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sequential photoactivatable metal-phenolic network enables spatiotemporally deep-tissue photoacoustic imaging-guided programmed photothermal therapy

  • 期刊论文

  • 发表日期：

    2025年11月17日

查看全文
  • Wenjing Tang,
  • Yaowen Jiang,
  • Xiangli Li,
  • Qin Xu,
  • Li-Ping Jiang,
  • Jingjing Zhang,
  • Jun-Jie Zhu

摘要

High spatiotemporal precision in targeted drug delivery and controlled activation remains a significant challenge in cancer theranostics due to the complex tumor microenvironment (TME). Here, we introduce a sequential near-infrared (NIR) light-assisted, TME-responsive nanoplatform (GA/cypate@MP-Pap) that employs a two-step NIR light activation strategy for in situ self-assembly of a metal-phenolic network, enabling deep-tissue photoacoustic (PA) imaging and enhanced photothermal therapy (PTT). Upon initial NIR light exposure, the nanoplatform activates thermophilic enzymes, triggering selective degradation of the tumor stroma, which significantly enhances its penetration into deeper tumor regions. Within the TME, the nanoplatform disassembles, releasing Mn2+ and GA that chelate to form photothermally potent metal-phenolic networks. A subsequent NIR light exposure then amplifies PA signals and PTT efficacy, precisely targeting tumor cells with minimized effects on normal tissues. This dual NIR light-triggered, enzyme-activated strategy provides a novel approach for imaging-guided cancer therapy with high precision both spatially and temporally.